Blog
RSS FeedPosted by Michael Wonder on 23 Nov 2016
TGA approves another Opdivo for another cancer type
23 November 2016 - The TGA has sanctioned the use of nivolumab for use by patients with renal cell carcinoma. ...
Posted by Michael Wonder on 17 Nov 2016
TGA approves Ninlaro
17 November 2016 - The TGA has approved Takeda's proteasome inhibitor for use by patients with multiple myeloma. ...
Posted by Michael Wonder on 14 Nov 2016
TGA key performance indicators: July 2015 to June 2016
14 November 2016 - The TGA has published a self-assessed rating of its overall performance for the year ending 30 ...
Posted by Michael Wonder on 02 Nov 2016
TGA publishes AusPAR for Esmya
2 November 2016 - The TGA has published an AusPAR for Vifor Pharma's Esmya. ...
Posted by Michael Wonder on 31 Oct 2016
TGA approves new combination product for type 2 diabetes
31 October 2016 - The TGA has approved AstraZeneca's Qtern (saxagliptin hydrochloride with dapagliflozin propanediol monohydrate). ...
Posted by Michael Wonder on 31 Oct 2016
TGA approves yet another use for Humira (adalimumab)
31 October 2016 - AbbVie clocks up another indication for its TNF-alfa inhibitor. ...
Posted by Michael Wonder on 18 Oct 2016
TGA publishes AusPAR for Keytruda
18 October 2016 - The TGA has finally published an AusPAR for MSD's PD-1 inhibitor. ...
Posted by Michael Wonder on 14 Oct 2016
TGA publishes AusPAR for Zurampic
14 October 2016 - The TGA has published an AusPAR for AstraZeneca's Zurampic. ...
Posted by Michael Wonder on 11 Oct 2016
TGA boss warns about streamlining approvals
3 October 2016 - The head of the Therapeutic Goods Administration, John Skerritt, has warned that federal government reforms to ...
Posted by Michael Wonder on 30 Sep 2016
Fast-track approval of medicines in Australia
30 September 2016 - The Australian Government has recently taken steps to fast track the registration of new medicines, generics, and ...
Posted by Michael Wonder on 28 Sep 2016
TGA performance statistics report: July 2015 to June 2016
28 September 2016 - The TGA, through the Performance Statistics Report, provides detailed statistical information on its performance to stakeholders. ...
Posted by Michael Wonder on 27 Sep 2016
Zinbryta approved by TGA
27 September 2016 - The TGA has approved Biogen's Zinbryta. ...
Posted by Michael Wonder on 19 Sep 2016
TGA pre-submission phase option for prescription medicines
19 September 2016 - The pre-submission pilot for prescription medicines will conclude at the end of September 2016 and continue as ...
Posted by Michael Wonder on 15 Sep 2016
Streamlined approvals means faster access to medicines for patients
15 September 2016 - Medicines Australia welcomes the commitment of the Australian Government to improve the way medicines are assessed for ...
Posted by Michael Wonder on 15 Sep 2016
TGA approves Simponi for axial spondyloarthritis
15 September 2016 - The TGA has approved a new use for Simponi. ...